窥得儿医药 QDEL 深 沪
已收盘 12-19 16:00:00 美东时间
28.95
+0.630
+2.22%
华盛通- 最 高29.38
- 今 开28.28
- 成交量 127.98万股
- 最 低 28.16
- 昨 收 28.32
- 总市值 19.67亿
- 52周最高 49.45
- 市盈率 静 --
- 换手率 1.88%
- 52周最低 19.50
- 委 比 30.30%
- 总股本 6793.15万
- 历史最高 306.724
- 量 比 1.46
- 振 幅 4.31%
- 历史最低 12.35
- 每 手 1
- 风险率 6.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Innovating Diagnostics and What's Next
SAN DIEGO, Dec. 18, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 54 of its Science Bytes podcast, featuring Jona...
12-18 22:17
QuidelOrtho To Participate In Upcoming Investor Conferences
SAN DIEGO, Nov. 24, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a global leader of in vitro diagnostics, announced today that members of its management team ...
11-24 20:00
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones gaining around 150 points on Friday....
11-22 00:14
The Power of Prevention: Detecting Diabetes Before It Strikes
SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 53 of its Science Bytes podcast, featuring Qian...
11-20 22:00
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
美股大行评级 | 绩后评级扎堆！高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；DoorDash、多邻国、Figma、飞塔信息、HubSpot等遭下调目标价
高通、ARM、礼来、Snap、Robinhood等获多家大行上调目标价；Adient、DoorDash、多邻国、Figma、飞塔信息、HubSpot、康丽数码等遭大行下调目标价
11-07 10:14
UBS Maintains Neutral on QuidelOrtho, Raises Price Target to $31
UBS analyst Lu Li maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and raises the price target from $26 to $31.
11-07 01:54
QuidelOrtho shares are trading higher after the company reported better-than-expected Q3 financial results.
QuidelOrtho shares are trading higher after the company reported better-than-ex...
11-06 22:26
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
